SUBSCRIBE
SUBSCRIBE

Eisai Company, Ltd. Announce Japan Launch of Oral Anticoagulant Warfarin Granules 0.2%

December 5, 2011 | 
1 min read
Tokyo, Nov 30, 2011 (JCN Newswire) - Eisai Co., Ltd. announced today that it will launch Warfarin Granules 0.2%, a new formulation of the company's oral anti-coagulant Warfarin (warfarin potassium), on December 1 in Japan.
Asia
MORE ON THIS TOPIC
Contemporary art collage. Motivated, confident team go over light background with abstract object, red arrows. Concept of business development, teamwork, startup, finance, career.
Job Trends
Biopharma cuts at manufacturing plants expected to affect 4,000+
October 29, 2026
 · 
5 min read
 · 
Angela Gabriel
3d pharmaceutical world icon with included clipping path.
Opinion
Biotechs going to market alone must learn to go global
October 28, 2026
 · 
3 min read
 · 
Paul Bridges
Perspective view of supermarket aisle. Supermarket with colorful shelves of merchandise and front door and supermarket food cart. Cartoon vector illustration
Immunology and inflammation
Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStar
October 23, 2026
 · 
1 min read
 · 
Annalee Armstrong
3d sketch poster trend collage image of hands hold chess figurine knight queen rival china america trade war economic problem.
China
US explores China biotech restrictions, exempts licensing deals
October 23, 2026
 · 
3 min read